Advertisement
Review| Volume 121, P13-21, March 2019

Methamphetamine and its immune-modulating effects

  • Marco Papageorgiou
    Affiliations
    Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia
    Search for articles by this author
  • Ali Raza
    Affiliations
    Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia
    Search for articles by this author
  • Sarah Fraser
    Affiliations
    Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia
    Search for articles by this author
  • Author Footnotes
    1 These authors have equal contribution to this work.
    Kulmira Nurgali
    Correspondence
    Corresponding authors at: Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
    Footnotes
    1 These authors have equal contribution to this work.
    Affiliations
    Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia

    Department of Medicine, The University of Melbourne, Regenerative Medicine and StemCells Program, Australian Institute of Musculoskeletal Science (AIMSS), Melbourne, VIC, Australia
    Search for articles by this author
  • Author Footnotes
    1 These authors have equal contribution to this work.
    Vasso Apostolopoulos
    Correspondence
    Corresponding authors at: Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
    Footnotes
    1 These authors have equal contribution to this work.
    Affiliations
    Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia
    Search for articles by this author
  • Author Footnotes
    1 These authors have equal contribution to this work.

      Highlights

      • Methamphetamine alters immune cells and signaling pathways.
      • Methamphetamine alters monocytes, macrophages, dendritic and natural killer cells, as well as T and B cells.
      • Methamphetamine alters astrocytes.
      • Methamphetamine alters cytokine and chemokine secretion.

      Abstract

      The recreational use of methamphetamine (METH, or ice) is a global burden. It pervades and plagues contemporary society; it has been estimated that there are up to 35 million users worldwide. METH is a highly addictive psychotropic compound which acts on the central nervous system, and chronic use can induce psychotic behavior. METH has the capacity to modulate immune cells, giving the drug long-term effects which may manifest as neuropsychiatric disorders, and that increase susceptibility to communicable diseases, such as HIV. In addition, changes to the cytokine balance have been associated with compromise of the blood–brain barrier, resulting to alterations to brain plasticity, creating lasting neurotoxicity. Immune-related signaling pathways are key to further evaluating how METH impacts host immunity through these neurological and peripheral modifications. Combining this knowledge with current data on inflammatory responses will improve understanding of how the adaptive and innate immunity responds to METH, how this can activate premature-ageing processes and how METH exacerbates disturbances that lead to non-communicable age-related diseases, including cardiovascular disease, stroke, depression and dementia.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cruickshank C.C.
        • Dyer K.R.
        A review of the clinical pharmacology of methamphetamine.
        Addiction. 2009; 104: 1085-1099
        • McKetin R.
        • Lubman D.I.
        • Najman J.M.
        • Dawe S.
        • Butterworth P.
        • Baker A.L.
        Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study.
        Addiction. 2014; 109: 798-806
        • McKetin R.
        • Dean O.M.
        • Baker A.L.
        • Carter G.
        • Turner A.
        • Kelly P.J.
        • et al.
        A potential role for N-acetylcysteine in the management of methamphetamine dependence.
        Drug Alcohol Rev. 2017; 36: 153-159
        • Degenhardt L.
        • Roxburgh A.
        • Black E.
        • Bruno R.
        • Campbell G.
        • Kinner S.
        • et al.
        The epidemiology of methamphetamine use and harm in Australia.
        Drug Alcohol Rev. 2008; 27: 243-252
        • Rebecca McKetin A.V.
        • Burns Richard
        Research into Methamphetamine Use in the Australian Capital Territory.
        National Drug Research Institute, Curtin University, Perth, Western Australia2017
        • Grant K.M.
        • LeVan T.D.
        • Wells S.M.
        • Li M.
        • Stoltenberg S.F.
        • Gendelman H.E.
        • et al.
        Methamphetamine-associated psychosis.
        J. Neuroimmune Pharmacol. 2012; 7: 113-139
        • Roche A.
        • McEntee A.
        Ice and the outback: patterns and prevalence of methamphetamine use in rural Australia.
        Aust. J. Rural Health. 2017; 25: 200-209
        • Montoya J.L.
        • Cattie J.
        • Morgan E.
        • Woods S.P.
        • Cherner M.
        • Moore D.J.
        • et al.
        The impact of age, HIV serostatus and seroconversion on methamphetamine use.
        Am. J. Drug Alcohol Abuse. 2016; 42: 168-177
        • Mukherjee A.
        • Dye B.A.
        • Clague J.
        • Belin T.R.
        • Shetty V.
        Methamphetamine use and oral health-related quality of life.
        Qual. Life Res. 2018; 27: 3179-3190
        • Larson S.A.
        • Desai R.
        • Kates F.R.
        Concerns about heroin, cocaine and methamphetamine: prevalence and correlates of at-risk users from 2015 National Survey on Drug Use and Health.
        J. Subst. Use. 2018; : 1-6
        • Barr Alasdair M.
        • William MacEwan G.
        • Thornton Allen E.
        • Honer William G.
        • Lecomte Tania
        The need for speed: an update on methamphetamine addiction.
        J. Psychiatry Neurosci. 2006; 31: 301-313
        • Sriram U.
        • Haldar B.
        • Cenna J.M.
        • Gofman L.
        • Potula R.
        Methamphetamine mediates immune dysregulation in a murine model of chronic viral infection.
        Front. Microbiol. 2015; : 6
        • Cabral G.A.
        Drugs of abuse, immune modulation, and AIDS.
        J. Neuroimmune Pharmacol. 2006; 1: 280-295
        • Loftis J.M.
        • Choi D.
        • Hoffman W.
        • Huckans M.S.
        Methamphetamine causes persistent immune dysregulation: a cross-species, translational report.
        Neurotox. Res. 2010; 20: 59-68
        • Peerzada H.
        • Gandhi J.A.
        • Guimaraes A.J.
        • Nosanchuk J.D.
        • Martinez L.R.
        Methamphetamine administration modifies leukocyte proliferation and cytokine production in murine tissues.
        Immunobiology. 2013; 218: 1063-1068
        • Mahajan SupriyaD.
        • Hu Z.
        • Reynolds Jessica L.
        • Aalinkeel Ravikumar
        • Schwartz Stanley A.
        • Nair Madhavan P.N.
        Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells.
        Mo. Diagn. Ther. 2006; 10: 257-269
        • Burns A.
        • Ciborowski P.
        Acute exposure to methamphetamine alters TLR9-mediated cytokine expression in human macrophage.
        Immunobiology. 2016; 221: 199-207
        • Coelho-Santos V.
        • Leitão R.A.
        • Cardoso F.L.
        • Palmela I.
        • Rito M.
        • Barbosa M.
        • et al.
        The TNF-α/Nf-κB signaling pathway has a key role in methamphetamine–induced blood–brain barrier dysfunction.
        J. Cereb. Blood Flow Metabol. 2015; 35: 1260-1271
        • Gonçalves J.
        • Martins T.
        • Ferreira R.
        • Milhazes N.
        • Borges F.
        • Ribeiro C.F.
        • et al.
        Methamphetamine-induced early increase of IL-6 and TNF-α mRNA expression in the mouse brain.
        Ann. New York Acad. Sci. 2008; 1139: 103-111
        • Harms R.
        • Morsey B.
        • Boyer C.W.
        • Fox H.S.
        • Sarvetnick N.
        Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of immunosuppression.
        PLoS One. 2012; 7e49897
        • Rosenblat Joshua D.
        • Mansur Rodrigo B.
        • McIntyre Roger S.
        Inflamed moods: a review of the interactions between inflammation and mood disorders.
        Progress Neuro-Psychopharmacol. Biol. Psychiatry. 2014; 53: 23-34
        • Geissmann Frederic
        • Jung Steffen
        • Sieweke Michael H.
        • Merad Miriam
        • Ley Klaus
        Development of monocytes, macrophages, and dendritic cells.
        Science. 2010; 327: 656-661
        • Gaskill P.J.
        • Calderon T.M.
        • Coley J.S.
        • Berman J.W.
        Drug induced increases in CNS dopamine alter monocyte, macrophage and t cell functions: implications for HAND.
        J. Neuroimm. Pharmacol. 2013; 8: 621-642
        • Prakash M.D.
        • Tangalakis K.
        • Antonipillai J.
        • Stojanovska L.
        • Nurgali K.
        • Apostolopoulos V.
        Methamphetamine: effects on the brain, gut and immune system.
        Pharmacol. Res. 2017; 120: 60-67
        • Liu X.
        • Silverstein P.S.
        • Singh V.
        • Shah A.
        • Qureshi N.
        • Kumar A.
        Methamphetamine increases LPS-mediated expression of IL-8, TNF-alpha and IL-1beta in human macrophages through common signaling pathways.
        PLoS One. 2012; 7e33822
        • Buchanan Jessica B.
        • Johnson Rodney W.
        A neurotoxic regimen of methamphetamine exacerbates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus.
        J. Neuroinflamm. 2010; 7
        • Reynolds J.L.
        • Law W.C.
        • Mahajan S.D.
        • Aalinkeel R.
        • Nair B.
        • Sykes D.E.
        • et al.
        Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages.
        J. Neuroimm. Pharmacol. 2012; 7: 673-685
        • Dudek A.M.
        • Martin S.
        • Garg A.D.
        • Agostinis P.
        Immature, semi-mature, and fully mature dendritic cells: toward a DC-Cancer cells interface that augments anticancer immunity.
        Front. Immunol. 2013; 4
        • Nair M.P.N.
        • Saiyed Z.M.
        • Nair N.
        • Gandhi N.H.
        • Rodriguez J.W.
        • Boukli N.
        • et al.
        Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells.
        J. Neuroimm. Pharmacol. 2008; 4: 129-139
        • Ankit Shah A.K.
        Methamphetamine-mediated endoplasmic reticulum (ER) stress induces type-1 programmed cell death in astrocytes via ATF6, IRE1a and PERK pathways.
        Oncotarget. 2016; 7
        • Groom Joanna R.
        • Richmond J.
        • Murooka Thomas T.
        • Sorensen Elizabeth W.
        • Sung Jung H.
        • Bankert K.
        • et al.
        CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ t helper 1 cell differentiation.
        Immunity. 2012; 37: 1091-1103
        • Potula R.
        • Haldar B.
        • Cenna J.M.
        • Sriram U.
        • Fan S.
        Methamphetamine alters T cell cycle entry and progression: role in immune dysfunction.
        Cell Death Discov. 2018; 4
        • Du S-H Qiao D.-F.
        • Chen C.-X.
        • Chen S.
        • Liu C.
        • Lin Z.
        • et al.
        Toll-like receptor 4 mediates methamphetamine-induced neuroinflammation through Caspase-11 signaling pathway in astrocytes.
        Front. Mol. Neurosci. 2017; 10
        • Potula R.
        • Hawkins B.J.
        • Cenna J.M.
        • Fan S.
        • Dykstra H.
        • Ramirez S.H.
        • et al.
        Methamphetamine causes mitrochondrial oxidative damage in human t lymphocytes leading to functional impairment.
        J. Immunol. 2010; 185: 2867-2876
        • Tomescu C.
        • Duh F.-M.
        • Lanier M.A.
        • Kapalko A.
        • Mounzer K.C.
        • Martin M.P.
        • et al.
        Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.
        Aids. 2010; 24: 2151-2160
        • Marcondes M.C.G.
        • Flynn C.
        • Watry D.D.
        • Zandonatti M.
        • Fox H.S.
        Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys.
        Am. J. Pathol. 2010; 177: 355-361
        • Aktas E.
        • Kucuksezer U.C.
        • Bilgic S.
        • Erten G.
        • Deniz G.
        Relationship between CD107a expression and cytotoxic activity.
        Cell Immunol. 2009; 254: 149-154
        • YANG F.C.
        • AGEMATSU K.
        • Nakazawa T.
        • MORI T.
        • KOBATA S.I.T.O.T.
        • Morimotoj C.
        • Komiyama A.
        CD27/CD70 interaction directly induces natural killer cell killing activity.
        Immunology. 1996; 88: 289-293
        • Bortell N.
        • Basova L.
        • Semenova S.
        • Fox H.S.
        • Ravasi T.
        • Marcondes M.C.
        Astrocyte-specific overexpressed gene signatures in response to methamphetamine exposure in vitro.
        J. Neuroinflamm. 2017; 14: 49
        • Sanderlin E.J.
        • Leffler N.R.
        • Lertpiriyapong K.
        • Cai Q.
        • Hong H.
        • Bakthavatchalu V.
        • et al.
        GPR4 deficiency alleviates intestinal inflammation in a mouse model of acute experimental colitis.
        Biochim. Biophys. Acta (BBA) – Mol. Basis Dis. 2017; 1863: 569-584
        • Tran T.-V.
        • Shin E.-J.
        • Nguyen L.T.T.
        • Lee Y.
        • Kim D.-J.
        • Jeong J.H.
        • et al.
        Protein kinase Cδ gene depletion protects against methamphetamine-induced impairments in recognition memory and ERK1/2 signaling via upregulation of glutathione Peroxidase-1 gene.
        Mol. Neurobiol. 2018; 55: 4136-4159
        • Soontornniyomkij V.
        • Kesby J.P.
        • Morgan E.E.
        • Bischoff-Grethe A.
        • Minassian A.
        • Brown G.G.
        • et al.
        Effects of HIV and methamphetamine on brain and behavior: evidence from human studies and animal models.
        J. Neuroimm. Pharmacol. 2016; 11: 495-510
        • Treadway JCFaMT
        Inflammation effects on motivation and motor activity: role of dopamine.
        Neuropsychopharmacology. 2017; 42: 216-241
        • Horiuchi T.
        • Mitoma H.
        • Si Harashima
        • Tsukamoto H.
        • Shimoda T.
        Transmembrane TNF-: structure, function and interaction with anti-TNF agents.
        Rheumatology. 2010; 49: 1215-1228
        • Chu W.M.
        Tumor necrosis factor.
        Cancer Lett. 2013; 328: 222-225
        • Dinarello C.A.
        Overview of the IL-1 family in innate inflammation and acquired immunity.
        Immunol. Rev. 2018; 281: 8-27
        • Kawai T.
        • Akira S.
        Signaling to NF-κB by toll-like receptors.
        Trends Mol. Med. 2007; 13: 460-469
        • Roman-Blas J.A.
        • Jimenez S.A.
        NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis.
        Osteoarthr. Cartil. 2006; 14: 839-848
        • Marcu Kenneth B.
        • Otero M.
        • Olivotto Eleonora
        • Borzi Rosa Maria
        • Mary B.
        Goldring. NF-κB signaling: multiple angles to target OA.
        Curr Drug Targets. 2010; 11: 599-613
        • SSIaG Cheng
        Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.
        Crit. Rev. Immunol. 2012; 32: 23-63
        • Glocker E.O.
        • Kotlarz D.
        • Boztug K.
        • Gertz E.M.
        • Schaffer A.A.
        • Noyan F.
        • et al.
        Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.
        N. Engl. J. Med. 2009; 361: 2033-2045
        • Fernandes Nicole C.
        • Sriram U.
        • Gofman Larisa
        • Cenna Jonathan M.
        • Ramirez Servio H.
        • Potula Raghava
        Methamphetamine alters microglial immune function through P2X7R signaling.
        J. Neuroinflamm. 2016; 13
        • Yan J.
        • Smyth M.J.
        • Teng M.W.L.
        Interleukin (IL)-12 and IL-23 and their conflicting roles in Cancer.
        Cold Spring Harb. Perspect. Biol. 2018; 10
        • Katrina Gee
        • Guzzo C.
        • Che Mat Nor Fazila
        • Ma Wei
        • Kumar Ashok
        The IL-12 family of cytokines in infection, inflammation and autoimmune disorders.
        Inflamm. Allergy - Drug Targets. 2009; 8: 40-52
        • Pop V.V.
        • Seicean A.
        • Lupan I.
        • Samasca G.
        • Burz C.C.
        IL-6 roles - molecular pathway and clinical implication in pancreatic cancer - a systemic review.
        Immunol. Lett. 2017; 181: 45-50
        • Ghasemi H.
        Roles of IL-6 in ocular inflammation: a review.
        Ocular Immunol. Inflamm. 2017; 26: 37-50
        • Lai K.S.P.
        • Liu C.S.
        • Rau A.
        • Lanctot K.L.
        • Kohler C.A.
        • Pakosh M.
        • et al.
        Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies.
        J. Neurol. Neurosurg. Psychiatry. 2017; 88: 876-882
        • Vanessa Coelho-Santos J.Ga
        • Fontes-Ribeiro Carlos
        • Silva Ana Paula
        Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway.
        J. Neuroinflamm. 2012; 9
        • Jin W.J.
        • Kim B.
        • Kim D.
        • Park Choo H.Y.
        • Kim H.H.
        • Ha H.
        • et al.
        NF-kappaB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells.
        Exp. Mol. Med. 2017; 49: e295
        • Wang Q.
        • Wei L.W.
        • Xiao H.Q.
        • Xue Y.
        • Du SH Liu Y.G.
        • et al.
        Methamphetamine induces hepatotoxicity via inhibiting cell division, arresting cell cycle and activating apoptosis: in vivo and in vitro studies.
        Food Chem. Toxicol. 2017; 105: 61-72
        • Bortell N.
        • Morsey B.
        • Basova L.
        • Fox H.S.
        • Marcondes M.C.
        Phenotypic changes in the brain of SIV-infected macaques exposed to methamphetamine parallel macrophage activation patterns induced by the common gamma-chain cytokine system.
        Front. Microbiol. 2015; 6: 900
        • Ankit Shah P.S.S.
        • Singh Dhirendra P.
        • Kumar Anil
        Involvement of metabotropic glutamate receptor 5, AKT/PI3K Signaling and NF- B pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes.
        J. Neuroinflamm. 2012; 9
        • Huckans M.
        • Fuller B.E.
        • Chalker A.L.
        • Adams M.
        • Loftis J.M.
        Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: an exploratory protein array study.
        Front. Psychiatry. 2015; 6: 178
        • Northrop N.A.
        • Yamamoto B.K.
        Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.
        Neuropharmacology. 2013; 72: 96-105
        • Thomas D.M.
        • Kuhn D.M.
        MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity.
        Brain Res. 2005; 1050: 190-198
        • Permpoonputtana K.
        • Govitrapong P.
        The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines.
        Neurotox. Res. 2013; 23: 189-199
        • Asanuma M.
        Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug.
        Neurosci. Lett. 2003;
        • Silverstein P.S.
        • Shah A.
        • Gupte R.
        • Liu X.
        • Piepho R.W.
        • Kumar S.
        • et al.
        Methamphetamine toxicity and its implications during HIV-1 infection.
        J. NeuroVirol. 2011; 17: 401-415
        • Jackson A.R.
        • Shah A.
        • Kumar A.
        Methamphetamine alters the normal progression by inducing cell cycle arrest in astrocytes.
        PLoS One. 2014; 9e109603
        • Pendyala G.
        • Zhu R.
        • Yang T.
        • Kobeissy F.
        • Mouhieddine T.H.
        • Raad M.
        • et al.
        The effect of chronic methamphetamine exposure on the hippocampal and olfactory bulb neuroproteomes of rats.
        PLoS One. 2016; 11
        • Sepuru K.M.
        • Poluri K.M.
        • Rajarathnam K.
        Solution structure of CXCL5--a novel chemokine and adipokine implicated in inflammation and obesity.
        PLoS One. 2014; 9e93228
        • Reynolds J.L.
        • Mahajan S.D.
        • Sykes D.E.
        • Schwartz S.A.
        • Nair M.P.N.
        Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC).
        Biochim. Biophys. Acta (BBA) - Proteins Proteom. 2007; 1774: 433-442
        • Serasanambati M.
        • Chilakapati S.R.
        Function of nuclear factor kappa B (NF-kB) in human diseases-a review.
        South Indian J. Biolog. Sci. 2016; 2
        • Sun S.-C.
        The non-canonical NF-κB pathway in immunity and inflammation.
        Nat. Rev. Immunol. 2017; 17: 545-558
        • Shabab T.
        • Khanabdali R.
        • Moghadamtousi S.Z.
        • Kadir H.A.
        • Mohan G.
        Neuroinflammation pathways: a general review.
        Int. J. Neurosci. 2016; 127: 624-633
        • Baker R.G.
        • Hayden M.S.
        • Ghosh S.
        NF-κB, inflammation, and metabolic disease.
        Cell Metab. 2011; 13: 11-22
        • Li F.C.
        • Yen J.C.
        • Chan S.H.
        • Chang A.Y.
        Bioenergetics failure and oxidative stress in brain stem mediates cardiovascular collapse associated with fatal methamphetamine intoxication.
        PLoS One. 2012; 7e30589
        • Nennig S.E.
        • Schank J.R.
        The role of NFkB in drug addiction: beyond inflammation.
        Alcohol Alcohol. 2017;
        • Yong Woo Lee B.H.
        • Yao Jin
        • Toborek Michal
        Methamphetamine induces AP-1 and NF- B binding and transactivation in human brain endothelial cells.
        J. of Neurosci. Res. 2001; 66: 583-591
        • Zhang Y.
        • Shu G.
        • Bai Y.
        • Chao J.
        • Chen X.
        • Yao H.
        Effect of methamphetamine on the fasting blood glucose in methamphetamine abusers.
        Metab. Brain Dis. 2018;
        • Sokolov B.P.
        • Cadet J.L.
        Methamphetamine causes alterations in the MAP kinase-related pathways in the brains of mice that display increased aggressiveness.
        Neuropsychopharmacology. 2005; 31: 956-966
        • Park J.-H.
        • Seo Y.H.
        • Jang J.-H.
        • Jeong C.-H.
        • Lee S.
        • Park B.
        Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway.
        J. Neuroinflamm. 2017; 14
        • Mao L.-M.
        • Reusch J.M.
        • Fibuch E.E.
        • Liu Z.
        • Wang J.Q.
        Amphetamine increases phosphorylation of MAPK/ERK at synaptic sites in the rat striatum and medial prefrontal cortex.
        Brain Res. 2013; 1494: 101-108
        • Huang Y.-N.
        • Wu C.-H.
        • Lin T.-C.
        • Wang J.-Y.
        Methamphetamine induces heme oxygenase-1 expression in cortical neurons and glia to prevent its toxicity.
        Toxicol. Appl. Pharmacol. 2009; 240: 315-326
        • Chu P.W.
        • Seferian K.S.
        • Birdsall E.
        • Truong J.G.
        • Riordan J.A.
        • Metcalf C.S.
        • et al.
        Differential regional effects of methamphetamine on dopamine transport.
        Eur. J. Pharmacol. 2008; 590: 105-110
        • Valjent E.
        • Corvol J.C.
        • Trzaskos J.M.
        • Girault J.A.
        • Herve D.
        Role of the ERK pathway in psychostimulant-induced locomotor sensitization.
        BMC Neurosci. 2006; 7: 20
        • Dan Dunn J.
        • Alvarez L.A.J.
        • Zhang X.
        • Soldati T.
        Reactive oxygen species and mitochondria: a nexus of cellular homeostasis.
        Redox Biol. 2015; 6: 472-485
        • Weston C.R.
        • Davis R.J.
        The JNK signal transduction pathway.
        Curr. Opin. Cell Biol. 2007; 19: 142-149
        • Jayanthi Subramaniam
        • McCoy M.T.
        • Ladenheim B.
        • Cadet J.eanLud
        Methamphetamine causes coordinate regulation of Src, Cas, Crk, and the jun N-terminal kinase–Jun pathway.
        Mol. Pharmacol. 2002; 61: 1124-1131
        • Yan T.
        • Li L.
        • Sun B.
        • Liu F.
        • Yang P.
        • Chen T.
        • et al.
        Luteolin inhibits behavioral sensitization by blocking methamphetamine-induced MAPK pathway activation in the caudate putamen in mice.
        PLoS One. 2014; 9e98981
        • Tocharus Jiraporn
        • Khonthun C.
        • Chongthammakun Sukumal
        • Govitrapong Piyarat
        Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines.
        J. Pineal Res. 2010; 48: 347-352
        • Hennessy B.T.
        • Smith D.L.
        • Ram P.T.
        • Lu Y.
        • Mills G.B.
        Exploiting the PI3K/AKT pathway for cancer drug discovery.
        Nat. Rev. Drug Discov. 2005; 4: 988-1004
        • Rau T.F.
        • Kothiwal A.
        • Zhang L.
        • Ulatowski S.
        • Jacobson S.
        • Brooks D.M.
        • et al.
        Low dose methamphetamine mediates neuroprotection through a PI3K-AKT pathway.
        Neuropharmacology. 2011; 61: 677-686
        • Niu T.
        • Li J.
        • Wang J.
        • Ma J.Z.
        • Li M.D.
        Identification of novel signal transduction, immune function, and oxidative stress genes and pathways by topiramate for treatment of methamphetamine dependence based on secondary outcomes.
        Front. Psychiatry. 2017; 8
        • Murray P.J.
        The JAK-STAT signaling pathway: input and output integration.
        J. Immunol. 2007; 178: 2623-2629
        • Vier J.
        • Groth M.
        • Sochalska M.
        • Kirschnek S.
        The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling.
        Cell Death Dis. 2016; 7 (e2103-e.)
        • Najafi Khadije S.A.
        • Rahpeyma Mahdi
        • Khazaie Habibolah
        • Vaisi-Raygani Asad
        • Moini Ali
        • Kiani Amir
        Study of serum malondialdehyde level in opioid and methamphetamine dependent patients.
        Acta Med. Iran. 2017; 55
        • Melo P.
        • Magalhaes A.
        • Alves C.J.
        • Tavares M.A.
        • de Sousa L.
        • Summavielle T.
        • et al.
        Methamphetamine mimics the neurochemical profile of aging in rats and impairs recognition memory.
        Neurotoxicology. 2012; 33: 491-499
        • García-Cabrerizo R.
        • García-Fuster M.J.
        Comparative effects of amphetamine-like psychostimulants on rat hippocampal cell genesis at different developmental ages.
        NeuroToxicology. 2016; 56: 29-39
        • Ye T.
        • Pozos H.
        • Phillips T.J.
        • Izquierdo A.
        Long-term effects of exposure to methamphetamine in adolescent rats.
        Drug Alcohol Depend. 2014; 138: 17-23
        • Franceschi C.
        • Campisi J.
        Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.
        J. Gerontol. A Biol. Sci. Med. Sci. 2014; 69: S4-S9
        • Winslow B.T.
        • Voorhees K.I.
        • Pehl K.A.
        Methamphetamine abuse.
        Am. Family Phys. 2007; 76: 1169-1174
        • Varner K.J.
        • Ogden B.A.
        • Delcarpio J.
        • Meleg-Smith S.
        Cardiovascular responses elicited by the "binge" administration of methamphetamine.
        J. Pharmacol. Exp. Ther. 2002; 301: 152-159
        • Henry B.L.
        • Minassian A.
        • Perry W.
        Effect of methamphetamine dependence on heart rate variability.
        Addict. Biol. 2012; 17: 648-658
        • Tan J.P.H.
        • Beilharz J.E.
        • Vollmer-Conna U.
        • Cvejic E.
        Heart rate variability as a marker of healthy ageing.
        Int. J. Cardiol. 2018; 5273: 31925-31929
        • Schurer S.
        • Klingel K.
        • Sandri M.
        • Majunke N.
        • Besler C.
        • Kandolf R.
        • et al.
        Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy.
        JACC Heart Fail. 2017; 5: 435-445
        • Nakou E.S.
        • Parthenakis F.I.
        • Kallergis E.M.
        • Marketou M.E.
        • Nakos K.S.
        • Vardas P.E.
        Healthy aging and myocardium: a complicated process with various effects in cardiac structure and physiology.
        Int. J. Cardiol. 2016; 209: 167-175
        • Chen L.
        • Yu P.
        • Zhang L.
        • Zou Y.
        • Zhang Y.
        • Jiang L.
        • et al.
        Methamphetamine exposure induces neuropathic protein beta-Amyloid expression.
        Toxicol. Vitro: Int. J. Publ. Assoc. BIBRA. 2018; 54: 304-309
        • Wirth K.J.
        Role of noradrenergic brain nuclei in the regulation of carotid artery blood flow: pharmacological evidence from anesthetized pigs with Alpha-2 adrenergic receptor modulator drugs.
        J. Alzheimer’s Dis.: JAD. 2018; 66: 407-419
        • Hardeland R.
        Recent findings in melatonin research and their relevance to the CNS.
        Centr. Nerv. Syst. Agents Med. Chem. 2018; 18: 102-114
        • Good R.L.
        • Radcliffe R.A.
        Methamphetamine-induced locomotor changes are dependent on age, dose and genotype.
        Pharmacol. Biochem. Behav. 2011; 98: 101-111
        • JG-G Butler B.
        • Prins P.
        • North A.
        • Clarke J.T.
        • Khoshbouei H.
        Chronic methamphetamine increases alpha-synuclein protein levels in the striatum and Hippocampus but not in the cortex of juvenile mice.
        J. Addict. Prev. 2014; 2
        • Thrash B.
        • Thiruchelvan K.
        • Ahuja M.
        • Suppiramaniam V.
        • Dhanasekaran M.
        Methamphetamine-induced neurotoxicity: the road to Parkinson’s disease.
        Pharmacol. Rep. 2009; 61: 966-977
        • Evren C.
        • Bozkurt M.
        Update on methamphetamine: an old problem that we have recently encountered.
        Dusunen Adam: J. Psychiatry Neurol. Sci. 2018; 31: 1-10
        • Panenka W.J.
        • Procyshyn R.M.
        • Lecomte T.
        • MacEwan G.W.
        • Flynn S.W.
        • Honer W.G.
        • et al.
        Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.
        Drug Alcohol Depend. 2013; 129: 167-179
        • McKetin Rebecca
        • Lubman D.I.
        • Lee Nicole M.
        • Ross Joanne E.
        • Slade Tim N.
        Major depression among methamphetamine users entering drug treatment programs.
        MJA. 2011; 195
        • Nakama H.
        • Chang L.
        • Fein G.
        • Shimotsu R.
        • Jiang C.S.
        • Ernst T.
        Methamphetamine users show greater than normal age-related cortical gray matter loss.
        Addiction. 2011; 106: 1474-1483
        • McDonnell-Dowling K.
        • Kelly J.P.
        The role of oxidative stress in methamphetamine-induced toxicity and sources of variation in the design of animal studies.
        Curr. Neuropharmacol. 2017; 15: 300-314
        • Morley J.E.
        • Baumgartner Richard N.
        Cytokine-related aging process.
        J. Gerontol. 2004; 59A: 924-929
        • Gomez C.R.
        • Karavitis J.
        • Palmer J.L.
        • Faunce D.E.
        • Ramirez L.
        • Nomellini V.
        • et al.
        Interleukin-6 contributes to age-related alteration of cytokine production by macrophages.
        Mediat. Inflamm. 2010; 2010: 1-7
        • Xia S.
        • Zhang X.
        • Zheng S.
        • Khanabdali R.
        • Kalionis B.
        • Wu J.
        • et al.
        An update on inflamm-aging: mechanisms, prevention, and treatment.
        J. Immunol. Res. 2016; 20168426874
        • Astarita G.
        • Avanesian A.
        • Grimaldi B.
        • Realini N.
        • Justinova Z.
        • Panlilio L.V.
        • et al.
        Methamphetamine accelerates cellular senescence through stimulation of de novo ceramide biosynthesis.
        PLoS One. 2015; 10e0116961
        • Bachi K.
        • Sierra S.
        • Volkow N.D.
        • Goldstein R.Z.
        • Alia-Klein N.
        Is biological aging accelerated in drug addiction?.
        Curr. Opin. Behav. Sci. 2017; 13: 34-39
        • Yang Z.
        • Ye J.
        • Li C.
        • Zhou D.
        • Shen Q.
        • Wu J.
        • et al.
        Drug addiction is associated with leukocyte telomere length.
        Sci. Rep. 2013; 3: 1542
        • Tipton D.A.
        • Legan Z.T.
        • Dabbous M.K.
        Methamphetamine cytotoxicity and effect on LPS-stimulated IL-1β production by human monocytes.
        Toxicol. Vitro. 2010; 24: 921-927
        • Mata M.M.
        • Napier T.C.
        • Graves S.M.
        • Mahmood F.
        • Raeisi S.
        • Baum L.L.
        Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse.
        Eur. J. Pharmacol. 2015; 752: 26-33
        • Saito Masayoshi
        • Terada M.
        • Kawata Tetsuya
        • Hisao
        • Shigematsu Naoyuki
        • Kromkhun Pudcharaporn
        • Yokosuka Makoto
        • Saito Toru R.
        Effects of single or repeated administrations of methamphetamine on immune response in mice.
        Exp. Anim. 2008; 57: 35-43
        • Hiroyuki Mizoguchi K.Y.
        • Mizuno Makoto
        • Mizuno Tomoko
        • Nitta Atsumi
        • Yukihiro Noda a T.N.
        Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-Like Gene-1 signaling pathway via the activation of dopamine receptors.
        Mol. Pharmacol. 2004; 65: 1293-1301
        • Cadet J.L.
        Epigenetics of stress, addiction, and resilience: therapeutic implications.
        Mol. Neurobiol. 2014; 53: 545-560